Approach to Address Limited Supply of BCG (OncoTICE)

By Tammy Northman | Latest news and stories | Comments are Closed | 12 November, 2018 | 0

Bladder Cancer Canada and its Medical Advisory Board have been advised by Merck Canada that they will be experiencing limited supply of Bacillus Calmette-Guerin (BCG) in the coming months.

Merck has established an allocation plan effective immediately and will keep information updated at https://www.drugshortagescanada.ca/drug/4066

Merck expects to fulfill between 75% and 100% of the normal demand during this time. Allocation based on historical customer orders has been implemented to ensure the available quantity is efficiently provided to patients. The anticipated end date is October 2019.

Below is an approach for consideration by physicians who treat bladder cancer to address the shortage of BCG should limited supply be realized.

Download the document here: Approach to Address BCG Shortage (Nov 2018)

The Medical Advisory Board of Bladder Cancer Canada and the CUA Guidelines Committee have reviewed and support these suggestions.

Bladder Cancer Canada will continue to update you as we receive more information.

No tags.

2019 Bladder Cancer Webinar Series

By Kerrya | Comments are Closed

Bladder Cancer Canada is pleased to offer our 2019 Bladder Cancer Webinar Series. These online events are presented live, and provide an opportunity for participants to learn in the comfort and privacy of their ownRead more
MEDIA RELEASE: World Bladder Cancer Patient Coalition

By Kerrya | Comments are Closed

MEDIA RELEASE New global bladder cancer patient organization launches For the first time ever, people affected by bladder cancer – the 10th most common cancer in the world, with more than half-a-million new cases reportedRead more
FREE EVENT – Demystifying Bladder Cancer: Optimizing your care and outcomes

By Kerrya | Comments are Closed

Bladder Cancer Canada invites patients, caregivers and loved ones to attend our free educational event “DEMYSTIFYING BLADDER CANCER: Optimizing your care and outcomes” on Wednesday, May 8, 2019. The meeting will take place in theRead more
Position Statement on Canadian Bacillus Calmette-Guérin (BCG) Shortage

By Kerrya | Comments are Closed

Bladder Cancer Canada Position Statement on Canadian Bacillus Calmette-Guérin (BCG) Shortage Issued March 7, 2019 Bacillus Calmette-Guérin (BCG) has been the standard of care for many patients with non-muscle invasive bladder cancer for decades. Bladder CancerRead more
Job Vacancy – Executive Director, World Bladder Cancer Patient Coalition

By Kerrya | Comments are Closed

Until now there has been no organization to speak as the global voice of people affected by bladder cancer and the organizations which represent them. Representatives of national bladder cancer organisations recognised this unmet needRead more
World Bladder Cancer Patient Coalition Launches

By Tammy Northman | Comments are Closed

WORLD BLADDER CANCER PATIENT COALITION LAUNCHES Until now there has been no organization to speak as the global voice of people affected by bladder cancer. Representatives of three major bladder cancer organisations including The BladderRead more
OTTAWA EDUCATION MEETING YIELDS VALUABLE INFORMATION AND RESOURCES

By Kerrya | Comments are Closed

Bladder Cancer Canada welcomed 80 patients, caregivers and family members to our Patient Education Meeting in Ottawa on November 21. We were fortunate to learn from three dynamic presenters and a panel of inspiring bladderRead more
Halifax Patient Meeting – Photo Slideshow

By Kerrya | Comments are Closed

https://bladdercancercanada.org/wp-content/uploads/2018/11/Fergs-video-of-Halifax-Pt-Mt-photos.mp4Read more